These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34388358)

  • 21. Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada.
    Skowronski DM; Setayeshgar S; Zou M; Prystajecky N; Tyson JR; Sbihi H; Fjell CD; Galanis E; Naus M; Patrick DM; El Adam S; Ahmed MA; Kim S; Henry B; Hoang LMN; Sadarangani M; Jassem AN; Krajden M
    J Infect Dis; 2022 Aug; 226(1):485-496. PubMed ID: 35084500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors for SARS-CoV-2 Infection and Illness in Cats and Dogs
    Bienzle D; Rousseau J; Marom D; MacNicol J; Jacobson L; Sparling S; Prystajecky N; Fraser E; Weese JS
    Emerg Infect Dis; 2022 Jun; 28(6):1154-1162. PubMed ID: 35608925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
    Pyke AT; Nair N; van den Hurk AF; Burtonclay P; Nguyen S; Barcelon J; Kistler C; Schlebusch S; McMahon J; Moore F
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada.
    Fibke CD; Joffres Y; Tyson JR; Colijn C; Janjua NZ; Fjell C; Prystajecky N; Jassem A; Sbihi H
    Front Public Health; 2022; 10():915363. PubMed ID: 35859775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
    Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
    EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Metapneumovirus Infections during COVID-19 Pandemic, Spain.
    García-García ML; Pérez-Arenas E; Pérez-Hernandez P; Falces-Romero I; Ruiz S; Pozo F; Casas I; Calvo C
    Emerg Infect Dis; 2023 Apr; 29(4):850-852. PubMed ID: 36878013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada.
    Tanunliong G; Liu AC; Kaweski S; Irvine M; Reyes RC; Purych D; Krajden M; Morshed M; Sekirov I; Gantt S; Skowronski DM; Jassem AN
    Front Immunol; 2022; 13():836449. PubMed ID: 35401521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction and rapid dissemination of SARS-CoV-2 Gamma Variant of Concern in Venezuela.
    Jaspe RC; Loureiro CL; Sulbaran Y; Moros ZC; D'Angelo P; Rodríguez L; Zambrano JL; Hidalgo M; Vizzi E; Alarcón V; Aguilar M; Garzaro DJ; ; Rangel HR; Pujol FH
    Infect Genet Evol; 2021 Dec; 96():105147. PubMed ID: 34800714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of COVID-19-related public health measures on HCV testing in British Columbia, Canada: An interrupted time series analysis.
    Binka M; Bartlett S; Velásquez García HA; Darvishian M; Jeong D; Adu P; Alvarez M; Wong S; Yu A; Samji H; Krajden M; Wong J; Janjua NZ
    Liver Int; 2021 Dec; 41(12):2849-2856. PubMed ID: 34592046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020.
    Claro IM; da Silva Sales FC; Ramundo MS; Candido DS; Silva CAM; de Jesus JG; Manuli ER; de Oliveira CM; Scarpelli L; Campana G; Pybus OG; Sabino EC; Faria NR; Levi JE
    Emerg Infect Dis; 2021 Mar; 27(3):970-972. PubMed ID: 33496249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.
    Galloway SE; Paul P; MacCannell DR; Johansson MA; Brooks JT; MacNeil A; Slayton RB; Tong S; Silk BJ; Armstrong GL; Biggerstaff M; Dugan VG
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(3):95-99. PubMed ID: 33476315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid screening for SARS-CoV-2 VOC-Alpha (202012/01, B.1.1.7) using the Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay.
    Giovacchini N; Coppi M; Aiezza N; Baccani I; Malentacchi F; Pollini S; Antonelli A; Rossolini GM
    Int J Infect Dis; 2021 Dec; 113():207-209. PubMed ID: 34628023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
    Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants.
    Migueres M; Lhomme S; Trémeaux P; Dimeglio C; Ranger N; Latour J; Dubois M; Nicot F; Miedouge M; Mansuy JM; Izopet J
    J Clin Virol; 2021 Oct; 143():104969. PubMed ID: 34509927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-Time Genomic Surveillance for SARS-CoV-2 Variants of Concern, Uruguay.
    Rego N; Costábile A; Paz M; Salazar C; Perbolianachis P; Spangenberg L; Ferrés I; Arce R; Fajardo A; Arleo M; Possi T; Reyes N; Bentancor MN; Lizasoain A; Benítez MJ; Bortagaray V; Moller A; Bello G; Arantes I; Brandes M; Smircich P; Chappos O; Duquía M; González B; Griffero L; Méndez M; Techera MP; Zanetti J; Rivera B; Maidana M; Alonso M; Alonso C; Medina J; Albornoz H; Colina R; Noya V; Iraola G; Fernández-Calero T; Moratorio G; Moreno P
    Emerg Infect Dis; 2021 Nov; 27(11):2957-2960. PubMed ID: 34437831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-Specific Changes in Virulence Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
    Fisman DN; Tuite AR
    Clin Infect Dis; 2022 Aug; 75(1):e69-e75. PubMed ID: 35234859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern.
    Yan T; Xu Y; Zheng R; Zeng X; Chen Z; Lin S; Xia Z; Liao Y; Zhang Y; Li Q
    Microbiol Spectr; 2022 Oct; 10(5):e0322222. PubMed ID: 36106882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptomatic and Asymptomatic Transmission of SARS-CoV-2 in K-12 Schools, British Columbia, Canada April to June 2021.
    Choi A; Mâsse LC; Bardwell S; Kayda I; Zhao Y; Xu YXZ; Markarian A; Coombs D; Macdonald A; Watts AW; Dhillon N; Irvine M; O'Reilly C; Lavoie PM; Goldfarb DM
    Microbiol Spectr; 2022 Aug; 10(4):e0062222. PubMed ID: 35862938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restaurant-Based Measures to Control Community Transmission of COVID-19, Hong Kong.
    Ho F; Tsang TK; Gao H; Xiao J; Lau EHY; Wong JY; Wu P; Leung GM; Cowling BJ
    Emerg Infect Dis; 2022 Mar; 28(3):759-761. PubMed ID: 35202535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatiotemporal Analyses of 2 Co-Circulating SARS-CoV-2 Variants, New York State, USA.
    Russell A; O'Connor C; Lasek-Nesselquist E; Plitnick J; Kelly JP; Lamson DM; St George K
    Emerg Infect Dis; 2022 Mar; 28(3):650-659. PubMed ID: 35133957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.